Clinical Trials
4
Active:0
Completed:1
Trial Phases
2 Phases
Phase 2:1
Phase 4:3
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 4
3 (75.0%)Phase 2
1 (25.0%)Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease
- First Posted Date
- 2011-01-25
- Last Posted Date
- 2011-01-25
- Lead Sponsor
- Shandong Luye Pharmaceutical Co., Ltd.
- Target Recruit Count
- 390
- Registration Number
- NCT01282619
- Locations
- 🇨🇳
Shanghai Mental Health Center, Shanghai, Shanghai, China
A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma
- First Posted Date
- 2008-03-25
- Last Posted Date
- 2008-05-14
- Lead Sponsor
- Shandong Luye Pharmaceutical Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT00642239
- Locations
- 🇨🇳
Beijing Cancer Hospital, Beijing, Beijing, China
🇨🇳Cancer Center of Sun Yat-sen University, Guangzhou, Guangdong, China
🇨🇳Zhongshan Hospital of Fudan University, Shanghai, Shanghai, China
China Cimicifuga Trial of Climacteric Complaint Control
Phase 4
- Conditions
- Climacteric Symptoms
- Interventions
- Drug: an extract of Cimicifuga Foetida L.Drug: placebo
- First Posted Date
- 2008-02-25
- Last Posted Date
- 2008-02-25
- Lead Sponsor
- Shandong Luye Pharmaceutical Co., Ltd.
- Target Recruit Count
- 288
- Registration Number
- NCT00622986
- Locations
- 🇨🇳
Fujian Provincal Maternal and Children Health Hospital, Fuzhou, Fujian, China
🇨🇳The First Affiliated Hospital，SUN YAT-SEN University, Guangzhou, Guangdong, China
🇨🇳Zhongnan University Xiangya No.3. Hospital, Changsha, Hunan, China
Pharmacokinetics Study of Liposomal Paclitaxel in Humans
- First Posted Date
- 2008-02-04
- Last Posted Date
- 2009-02-10
- Lead Sponsor
- Shandong Luye Pharmaceutical Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT00606515
- Locations
- 🇨🇳
Cancer Hospital of Fudan University, Shanghai, China
News
No news found